HFA Premium Access

The effect of sacubitril/valsartan on device detected arrhythmias and electrical parameters among cardiac resynchronization therapy implanted patients with moderately reduced ejection fraction

Topic: Cardiac Resynchronisation Therapy (CRT)

Congress Presentation

About the speaker

Doctor Gulnoza Dussekeyeva

Central Clinical Hospital of Medical Center of Presidentƒ??s Affairs Administration, Almaty (Kazakhstan)
1 presentation
0 follower

738 more presentations in this session

Atrial lead insertion during cardiac implantable electronic devices implantation in patients with atrial arrhythmia on hospital admission, when does the struggle for sinus rhythm make sense?

Speaker: Assistant Professor N. Radovanovic (Belgrade, RS)

Thumbnail

Features of the remodeling of atria and pulmonary veins in CHF patients with paroxysmal AF and permanent AF

Speaker: Assistant Professor V. Kirillova (Ekaterinburg, RU)

Thumbnail

Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum

Speaker: Doctor D. Moysidis (Thessaloniki, GR)

Thumbnail

Impact of cardiac contractility modulation on ventricular rhythm and conduction disorders in patients with heart failure with reduced ejection fraction and various forms of atrial fibrillation

Speaker: Doctor A. Safiullina (Moscow, RU)

Thumbnail

Was a difference between late and early new-onset of atrial fibrillation in non st-elevation myocardial infarction?

Speaker: Doctor H. Santos (Lisboa, PT)

Thumbnail

Access the full session

ePoster session

Speakers: Doctor G. Dussekeyeva, Assistant Professor N. Radovanovic, Assistant Professor V. Kirillova, Doctor D. Moysidis, Doctor A. Safiullina...
Thumbnail

About the event

Image

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb